Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MOREReimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development OverviewGenerate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEWElevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEWOrchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEWWhen your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSAn in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTSBy making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MOREBuilding on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MOREThe IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MOREThe IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MOREIQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MOREEmpowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm.
LEARN MOREOur mission is to accelerate innovation for a healthier world. Together, we can solve customer challenges and improve patient lives.
LEARN MORECareers, culture and everything in between. Find out what’s going on right here, right now.
LEARN MORE"Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.
SEARCH JOBSLa categoría de tos, resfriados y otros productos respiratorios continúan presentando gran peso en el mercado facturando 83,7M€ desde marzo 2021 a febrero 2022. Además, presentan un crecimiento a triple dígito vs el acumulado de marzo 2022 a febrero 2023, relacionado con el mayor uso de las mascarillas debido a la variante Ómicron, lo cual frenó el contagio de enfermedades respiratorias del año pasado. Dentro de esta categoría los productos que presentan una mayor cuota de mercado son los antigripales y anticatarrales.
Debido a las recientes oleadas de gripe, la venta de los tests combinados ha incrementado facturando en febrero 1,9 M€. Dentro de esta categoría presenta mayor cuota de mercado los duales para la detección de la COVID y gripe.
La mayor concienciación de la salud intestinal tiene impacto directo en la venta de mayores volúmenes de probióticos cuya función principal es ayudar a mantener un equilibrio saludable en las bacterias intestinales. En concreto, este mes presentan una facturación de 7,9 M€.
El indicador de incremento de precios de la farmacia ha subido 0,2 puntos porcentuales mientras que el IPC ha aumentado 0,1 puntos. De esta manera, el crecimiento interanual de precios en el mercado Consumer Health (excluyendo medicamentos publicitarios, categorías COVID y mercados reembolsados) es del 3,3%, mientras que la inflación se sitúa en el 6,0%.